Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toronto Research Chemicals (TRC) is a leading manufacturer of complex organic small molecules for biomedical research and drug discovery. Founded in 1982 and headquartered in Toronto, Canada, the company provides an extensive catalog of over 350,000 products, including reference standards, stable isotopes, and chemical impurities. TRC's products are essential for pharmaceutical companies, forensic laboratories, and environmental agencies worldwide to ensure the safety and efficacy of new therapeutics. In 2019, TRC was acquired by LGC Group, integrating its vast chemical library into LGC's global science and measurement portfolio. The company continues to operate as a premier supplier of specialized chemicals that are often unavailable from other commercial sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toronto Research.